VIVENK Trademark

Trademark Overview

On Friday, November 27, 2020, a trademark application was filed for VIVENK with the United States Patent and Trademark Office. The USPTO has given the VIVENK trademark a serial number of 79300658. The federal status of this trademark filing is REGISTERED as of Tuesday, April 9, 2024. This trademark is owned by Glycostem Therapeutics B.V.. The VIVENK trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products and preparations containing natural killer cells for the treatment of cancer; medical cell products for the treatment of cancer in the nature of natural killer cells for use in immuno-oncology
vivenk

General Information

Serial Number79300658
Word MarkVIVENK
Filing DateFriday, November 27, 2020
Status700 - REGISTERED
Status DateTuesday, April 9, 2024
Registration Number7349251
Registration DateTuesday, April 9, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 23, 2024

Trademark Statements

Goods and ServicesPharmaceutical products and preparations containing natural killer cells for the treatment of cancer; medical cell products for the treatment of cancer in the nature of natural killer cells for use in immuno-oncology

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 28, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlycostem Therapeutics B.V.
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressNL
Party NameGlycostem Therapeutics B.V.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNL
Party NameGlycostem Therapeutics B.V.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNL

Trademark Events

Event DateEvent Description
Friday, May 21, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, December 24, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, December 28, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 1, 2021APPLICATION FILING RECEIPT MAILED
Thursday, May 13, 2021ASSIGNED TO EXAMINER
Wednesday, May 19, 2021NON-FINAL ACTION WRITTEN
Thursday, May 20, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, May 21, 2021REFUSAL PROCESSED BY MPU
Sunday, June 13, 2021REFUSAL PROCESSED BY IB
Tuesday, December 14, 2021FINAL REFUSAL E-MAILED
Thursday, November 18, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 18, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 18, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 14, 2021FINAL REFUSAL WRITTEN
Tuesday, December 14, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, June 14, 2022EXPARTE APPEAL RECEIVED AT TTAB
Wednesday, May 25, 2022NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, May 25, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sunday, June 12, 2022NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Friday, June 24, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 14, 2022JURISDICTION RESTORED TO EXAMINING ATTORNEY
Tuesday, June 14, 2022EX PARTE APPEAL-INSTITUTED
Tuesday, June 14, 2022TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, June 24, 2022ASSIGNED TO LIE
Friday, June 24, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 12, 2022ACTION CONTINUING FINAL - COMPLETED
Tuesday, July 12, 2022ACTION DENYING REQ FOR RECON E-MAILED
Tuesday, July 12, 2022NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Thursday, December 7, 2023JURISDICTION RESTORED TO EXAMINING ATTORNEY
Monday, December 18, 2023EXPARTE APPEAL TERMINATED
Wednesday, January 3, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 3, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 3, 2024NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Saturday, December 9, 2023NEW REPRESENTATIVE AT IB RECEIVED
Monday, December 18, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 23, 2024PUBLISHED FOR OPPOSITION
Tuesday, January 23, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, January 22, 2024NOTIFICATION PROCESSED BY IB
Tuesday, April 9, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, April 9, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Saturday, October 19, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Related Keywords

vivenk killer treatment cancer natural cells products nature immuno oncology cell